Remus Pharmaceuticals Limited (NSE:REMUS)
India flag India · Delayed Price · Currency is INR
804.00
-16.50 (-2.01%)
Nov 11, 2026, 1:24 PM IST

Remus Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
412.5369.9290.7205.285.0334.34
Depreciation & Amortization
31.929.418.6114.641.55
Other Amortization
0.10.10.10.20.13-
Loss (Gain) From Sale of Assets
-0.2-0.2-2.1---
Other Operating Activities
36.9119.193.521.7-3.93-1.72
Change in Accounts Receivable
151.3-318.172.6-481.2-19.336.89
Change in Inventory
310.1-205-84.4-7.713.02-4.39
Change in Accounts Payable
-509.947.6-224.1390.2-15.0714.97
Change in Other Net Operating Assets
-272.9138.8-95.1-125.9-11.36-1.26
Operating Cash Flow
159.8181.669.813.553.1350.38
Operating Cash Flow Growth
135.69%160.17%417.04%-74.59%5.46%77.52%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-135.7-145.7-39.8-32.9-27.32-0.71
Sale of Property, Plant & Equipment
8.88.83---
Cash Acquisitions
----87.3--
Investment in Securities
-168.7-188.62.732.6-175.48-30.01
Other Investing Activities
75.0162.4-42.5-178.33.452.44
Investing Cash Flow
-193.49-150.3-105.5-301.1-151.92-45.45

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
--89.3---
Long-Term Debt Issued
-41.93.323.577.51-
Total Debt Issued
25.941.992.623.577.51-
Short-Term Debt Repaid
--1.1--6.4--
Long-Term Debt Repaid
---5.1-58.6--0.87
Lease Payments
---5.1---
Total Debt Repaid
72.5-1.1-5.1-65--0.87
Net Debt Issued (Repaid)
98.440.887.5-41.577.51-0.87
Issuance of Common Stock
---46742.5-
Common Dividends Paid
-12.4-11.8-11.8-5.9--
Other Financing Activities
-18.7-14.3-15-142.9-2.33-0.87
Financing Cash Flow
67.314.760.7276.7117.69-1.74

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-0.11-0.10.1480-
Net Cash Flow
33.545.925.137.118.93.18

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
24.135.930-19.425.8149.67
Free Cash Flow Growth
7.59%19.67%---48.03%79.21%
Free Cash Flow Margin
0.22%0.42%0.48%-0.91%5.72%20.09%
Free Cash Flow Per Share
1.973.055.09-1.723.166.21
Levered Free Cash Flow
-17.1427.18-103.88-394.057.4542.87
Unlevered Free Cash Flow
-7.2636.36-94.75-390.928.7343.36
Free Cash Flow After Leases
24.135.924.9-19.425.8149.67

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
14.714.714.652.330.87
Cash Income Tax Paid
94.694.674.758.129.9711.94
Change in Working Capital
-321.4-336.7-331-224.6-32.7416.21